Form 4: Haemonetics Corp Executive Stewart W. Strong Reports Stock Transactions
SEC Form 4
Stewart W. Strong, President, Global Hospital at Haemonetics Corp, reports stock transactions including sales and option exercises on May 15 and 16, 2024.
Summary
- On May 15, 2024, Stewart W. Strong disposed of 241 shares of Haemonetics Corp common stock at a price of $96.49 per share to cover tax obligations related to vesting restricted stock units.
- On May 16, 2024, Strong disposed of 252 shares at $94.8 per share for tax obligations.
- Also on May 16, 2024, Strong exercised options to acquire 2,410 shares at $57.6 per share and sold 733 shares at $96.04 per share.
- An additional 1,677 shares were disposed of at $96.14 per share to cover tax obligations and the exercise price of the stock options.
- These transactions were executed under a pre-existing 10b5-1 trading plan dated June 12, 2023.
- Following these transactions, Strong beneficially owns 15,608 shares of common stock and 4,821 non-qualified stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports stock transactions by an executive, which are part of a pre-existing trading plan and related to tax obligations and option exercises.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Comparison to Industry Standards
- Executive stock transactions are a normal part of compensation and wealth management in publicly traded companies.
- The use of 10b5-1 trading plans is a common practice to avoid accusations of insider trading, aligning with industry best practices.
- Comparable companies such as Baxter International and Medtronic also see regular Form 4 filings from their executives.
Key Dates
| Date | Description |
|---|---|
| 06/12/2023 | Date of the 10b5-1 trading plan. |
| 05/15/2024 | Date of first reported transaction (share disposal for tax obligations). |
| 05/16/2024 | Date of multiple transactions: share disposal, option exercise, and share sale. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.